Quest Diagnostics

Aktuelle Nachrichten

Schlagzeilen in der Originalsprache der Quelle.

• Interested In Quest Diagnostics' (NYSE:DGX) Upcoming US$0.86 Dividend? You Have Three Days Left (öffnet in neuem Tab)

  Simply Wall Street · 02.10.2026

• Quest Diagnostics (NYSE:DGX) Breakout Setup Backed by Technical Rating 7 and Setup Rating 8 (öffnet in neuem Tab)

  ChartMill · 02.10.2026

• Quest Diagnostics’ Haystack MRD shows efficacy in colorectal cancer detection (öffnet in neuem Tab)

  TipRanks · 01.10.2026

• Quest Diagnostics (DGX) Highlights Haystack MRD Test Accuracy in Colorectal Cancer Trials (öffnet in neuem Tab)

  GuruFocus · 01.10.2026

• Quest Diagnostics stock pre-market at EUR 206.40: plus 0.22 percent (öffnet in neuem Tab)

  AD HOC NEWS · 01.10.2026

• Quest Diagnostics (DGX) Could Be 6% Undervalued After Florida ECG Screening Push (öffnet in neuem Tab)

  Simply Wall Street · 01.10.2026

• Quest Diagnostics (DGX) Q1 2026 Earnings Call Transcript (öffnet in neuem Tab)

  Fortune · 30.09.2026

• Quest Diagnostics Incorporated (DGX) stock price, news, quote and history (öffnet in neuem Tab)

  Yahoo Finance UK · 30.09.2026

• Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors (öffnet in neuem Tab)

  MarketWatch · 29.09.2026

• RENX: Quest Diagnostics partnership enables national reach and margin gains for kidneyintelX.dkd (öffnet in neuem Tab)

  TradingView · 29.09.2026

• Quest Diagnostics stock heads toward October 22 results (öffnet in neuem Tab)

  AD HOC NEWS · 29.09.2026

• Quest Diagnostics stock draws a USD 260.00 target after earnings (öffnet in neuem Tab)

  AD HOC NEWS · 28.09.2026

• How Cancer Test Approval At Quest Diagnostics (DGX) Has Changed Its Investment Story (öffnet in neuem Tab)

  Simply Wall Street · 26.09.2026

• Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally? (öffnet in neuem Tab)

  TradingView · 25.09.2026

• Quest Diagnostics stock gains 1.48 percent after Truist raises target (öffnet in neuem Tab)

  AD HOC NEWS · 25.09.2026

• Quest Diagnostics stock heads into the open after a 0.4 percent gain (öffnet in neuem Tab)

  AD HOC NEWS · 25.09.2026

• Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX) (öffnet in neuem Tab)

  The Globe and Mail · 24.09.2026

• Quest Diagnostics stock reports growth as reimbursement risk rises (öffnet in neuem Tab)

  AD HOC NEWS · 24.09.2026

• Quest Diagnostics (DGX) Apple Health Push Leaves Valuation Question Open (öffnet in neuem Tab)

  Simply Wall Street · 24.09.2026

• Quest Diagnostics (DGX) Could Be 5% Below Fair Value After Apple Health Launch (öffnet in neuem Tab)

  Yahoo Finance · 23.09.2026

• Quest Diagnostics shows growth potential despite Medicare uncertainties, driven by testing demand and acquisitions. (öffnet in neuem Tab)

  Pluang · 23.09.2026

• Barclays Maintains Quest Diagnostics(DGX.US) With Buy Rating, Maintains Target Price $250 (öffnet in neuem Tab)

  moomoo.com · 23.09.2026

• Quest Diagnostics stock falls as Medicare cuts threaten 2027 earnings (öffnet in neuem Tab)

  AD HOC NEWS · 23.09.2026

• Quest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare Headwinds (öffnet in neuem Tab)

  Seeking Alpha · 23.09.2026

• Apple, Quest Diagnostics partner on in-app lab orders (öffnet in neuem Tab)

  Healthcare Brew · 22.09.2026

• Quest Diagnostics, Labcorp Shares Fall as Medicare Signals Cuts in Payment Rates for Lab Services (öffnet in neuem Tab)

  marketscreener.com · 22.09.2026

• Is Quest Diagnostics Stock Outperforming the Nasdaq? (öffnet in neuem Tab)

  barchart.com · 22.09.2026

• Stocks making the biggest moves premarket: Alibaba, Quest Diagnostics, On Holding, GameStop & more (öffnet in neuem Tab)

  CNBC · 22.09.2026

• Evercore sees Lab Corp, Quest shares facing Medicare pricing headwind (öffnet in neuem Tab)

  Investing.com · 22.09.2026

• Quest Diagnostics (DGX) Stock Could Be 30% Below Fair Value Following Medicare Payment Cut Concerns (öffnet in neuem Tab)

  Yahoo Finance · 22.09.2026